Biohaven Ltd.|4Jan 7, 8:49 PM ET

Buten Matthew 4

4 · Biohaven Ltd. · Filed Jan 7, 2025

Form 4

Period: 2025-01-05

Chief Financial Officer

Transactions

Exercise/Conversion
Common Shares
2025-01-05+4,250→ 196,013 total
Tax Payment
Common Shares
2025-01-05$38.64/sh−2,561$98,957→ 193,452 total
Award
Stock Options (Right to buy)
2025-01-05+104,000→ 104,000 total
Exercise: $38.64Exp: 2035-01-05→ Common Shares (104,000 underlying)
Award
Restricted Share Unit Award
2025-01-05+17,000→ 17,000 total
→ Common Shares (17,000 underlying)
Exercise/Conversion
Restricted Share Unit Award
2025-01-05−4,250→ 12,750 total
→ Common Shares (4,250 underlying)

Footnotes (6)

[F1]This balance includes 305 shares that were acquired through the Biohaven Employee Share Purchase Plan (the "ESPP") on May 31, 2023, 1,336 shares acquired through the ESPP on November 30, 2023, and 742 shares acquired through the ESPP on May 31, 2024.
[F2]No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units.
[F3]The shares underlying this option vest in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service with the Issuer at each vesting date.
[F4]Each restricted share unit represents the contingent right to receive one common share of the Issuer.
[F5]The reporting person was granted 17,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date.
[F6]Not applicable.

Documents

1 file